Angiosarcomas Treatment Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Sarcoma is a group of soft tissue tumors and a rare and clinically variable type of cancer that originates due to the transformation of mesenchymal cells. Angiosarcomas mainly occurs in the breast, bone, skin, soft tissues, and spleen. It grows in the cells of blood vessels and spreads into various parts of the body that affects the normal activity. This type of tumor has rapidly multiplying cancerous cells, which originated from mesenchymal or endothelial source. Such tumors typically appears on skin and face and while high growth of these tumors they can increases the risk of mortality. The severity and spreading area of the disease is projected to be one of the major cause that will support growth of the angiosarcomas treatment market over the forecast period.

There are various types of angiosarcomas such as Epithelioid Angiosarcoma, Cardiac Angiosarcoma, Hepatic Angiosarcoma and Cutaneous Angiosarcoma. As per the stats of Know Cancer (this institute known for connecting cancer infected people to empower and educate them about cancer) cutaneous angiosarcomas contributes to the maximum of angiosarcomas cases, which is around 60% followed by angiosarcomas found in deep tissue and in breast tissue contributes around 35% in overall cases. Skin lesions, bone pain, fatigue, anemia and heart pain are some symptoms of angiosarcomas, though these vary according to location of angiosarcomas.

The treatment options available for angiosarcomas are surgery, chemotherapy and radiotherapy. Furthermore, according to the National Cancer Institute (NCI), the survival rate is around 5 year after diagnosis which is found in 50% of the people having angiosarcomas. The people who respond to treatment and show some recovery in first 5 years after diagnosis of angiosarcomas, have more chances of survival. According to the data published by NCI in 2014, based on 5 years study the survival rate for sarcoma was pegged at 90% those in first stage, 81% at second stage, 56% during third stage and during fourth stage there is no survival rate available. Also, some diagnostics tests such as CT, PET, MRI scan and biopsy test for the effective diagnosis of angiosarcomas.

As per results of a study by Coherent Market Insights, in August 2015, the incidence rate for this disease is very low, with angiosarcomas contributing 1-2% towards sarcoma cases. Rapid surge in number of cancer cases worldwide inadvertently creates a highly conducive environment for growth of the angiosarcomas treatment market.

As per the stats published by European Medicines Agency in January, there are around 3.5 in 10,000 people affected by angiosarcomas in Europe, in 2016. While in U.S. as per the stats of Know Cancer, angiosarcomas account for only 0.7% of cancer cases which makes it very rare type of cancer.

Angiosarcomas treatment market taxonomy:

Global Market by location of Instigation

  • Hemangiosarcoma
  • Lymphangiosarcoma

Global Market by Type of Treatment

  • Surgery
  • Chemotherapy
  • Radiotherapy

Global Market by Geography

  • North America
  • Europe
  • APAC
  • Latin America
  • Middle East
  • Africa

Expected rise in prevalence of angiosarcomas disease and increase in research and development into cancer treatment drugs are the major factors driving the growth of angiosarcomas treatment market

As the major research and development activities in the area of cancer are mostly performed in North America region, it holds the major market share of angiosarcomas treatment market followed by Europe backboned by increased healthcare infrastructure development, affordability of drugs, developed treatment options and high awareness about available treatments.

Increase in number of cancer cases and growing awareness regarding the treatments in emerging economies are expected to contribute majorly in the growth of angiosarcomas treatment market. Furthermore, growth in per capita income is projected to support the high health care spending by the population, which in turn is expected to favor the growth in angiosarcomas treatment industry in the near future.

As the disease is rare, only few organizations are investing in research and development and high cost of the drugs are the growth restraining factors of market in angiosarcomas treatment. However, considering the projected increase in incidence of the disease in the near future, the market is expected to witness the entry of various new players.

Major companies involved in the angiosarcomas treatment market include Genentech, Inc., Pfizer Inc., Janssen Global Services, LLC, Bayer AG, Sanofi, Amgen Inc., also some innovative leading drugs include irinotecan, sildenafil, bevacizumab, BAY43-9006, and SU11248.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.
Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.